Parent Categories
Health Care
-
Reproductive Technologies and Embryo Destruction After Dobbs
December 4, 2024
I. Glenn Cohen, Reproductive Technologies and Embryo Destruction After Dobbs, in Roe v. Dobbs: The Past, Present and Future of a Constitutional Right of Abortion…
-
The Reply
December 4, 2024
Eli Y. Adashi & I. Glenn Cohen, The Reply, 136 Am. J. Med. (2023).
-
Should the Administration for Strategic Preparedness and Response Lead the National Response to a Public Health Emergency?
December 4, 2024
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, Should the Administration for Strategic Preparedness and Response Lead the National Response to a Public…
-
Integrity of SARS-CoV-2 Laboratory-Developed Tests—Reply
December 4, 2024
Eli Y. Adashi & I. Glenn Cohen, Integrity of SARS-CoV-2 Laboratory-Developed Tests—Reply, 328 JAMA 478 (2022).
-
Emerging Ethical Considerations for the Use of Artificial Intelligence in Ophthalmology
December 4, 2024
Nicholas G. Evans, Danielle M. Wenner, I. Glenn Cohen et al., Emerging Ethical Considerations for the Use of Artificial Intelligence in Ophthalmology, 2 Ophthalmology Sci. 1…
-
The FDA Struggle to Withdraw Makena
December 4, 2024
Daniel G. Aaron, I. Glenn Cohen & Eli Y. Adashi, The FDA Struggle to Withdraw Makena, JAMA (2022).
-
Traveling Across States for Prohibited Treatments: Medical Aid in Dying and Looming Battles Over Abortion
December 4, 2024
I. Glenn Cohen, Eli Y. Adashi & Thaddeus M. Pope, Traveling Across States for Prohibited Treatments: Medical Aid in Dying and Looming Battles Over Abortion,…
-
The PREVENT Pandemics Act: A National Road Map
December 4, 2024
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, The PREVENT Pandemics Act: A National Road Map, Am. J. Preventative Med. (2022).
-
Travel to Other States for Abortion after Dobbs
December 4, 2024
I. Glenn Cohen, Travel to Other States for Abortion after Dobbs, 22 Am. J. Bioethics 42 (2022).
-
I. Glenn Cohen & Eli Y. Adashi, The Enduring Allure of Person-Affecting Arguments for Reproductive Technologies, 22 Am. J. Bioethics 44 (2022).
-
Winston McCormick, Eli Y. Adashi & I. Glenn Cohen, Expanding the Blood Pool: The Limitations of the FDA’S Current MSM Blood Deferral, 97 Mayo Clinic…
-
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, And Then There Were Three: The Decimation of the Affordable Care Act (ACA) CO-OPs, 35…
-
Genomic Politics and Equality
December 4, 2024
I. Glenn Cohen, Genomic Politics and Equality, 2 Am. J. L. & Equal. 373 (2022) (reviewing Jennifer Hochschild, Genomic Politics: How the Revolution in Genomic…
-
When Is a Change Significant? The Update Problem of Apps in Medical and Behavioral Research
December 4, 2024
Carmel Shachar, Sara Gerke, Walker Morrell et al., When Is a Change Significant? The Update Problem of Apps in Medical and Behavioral Research, 44 Ethics…
-
The Nursing Home Crisis: Prognosis Guarded
December 4, 2024
Eli Y. Adashi & I. Glenn Cohen, The Nursing Home Crisis: Prognosis Guarded, 135 Am. J. Med. 1150 (2022).
-
Eli Y. Adashi & I. Glenn Cohen, The CMS Vaccine Mandate at the Supreme Court: A Hippocratic Imperative, Am. J. Med. (2022).
-
Handle with Care: The WHO Report on Human Genome Editing
December 4, 2024
I. Glenn Cohen, Jacob S. Sherkow & Eli Y. Adashi, Handle with Care: The WHO Report on Human Genome Editing, 52 Hastings Center Rep. 10…
-
Stamping Out the Medicaid Coverage Gap: An ACA Imperative
December 4, 2024
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, Stamping Out the Medicaid Coverage Gap: An ACA Imperative, Am. J. Med. (2022).
-
Who will oversee the ethical limits of human embryo research?
December 4, 2024
Eli Y. Adashi & I. Glenn Cohen, Who Will Oversee the Ethical Limits of Human Embryo Research?, 40 Nature Biotechnology 463 (2022).
-
Health Care Fraud: The Leading Violation of the False Claims Act
December 4, 2024
Eli Y. Adashi & I. Glenn Cohen, Health Care Fraud: The Leading Violation of the False Claims Act, Am. J. Med. (2022).
-
The next two decades of mifepristone at FDA: History as destiny
December 4, 2024
Eli Y. Adashi et al., The next two decades of mifepristone at FDA: History as destiny, Contraception (2022).